Uncovering Answers to Protect Patients' Health
Boehringer Ingelheim has a large and experienced global team managing and conducting clinical trials in many indications.
Basic Information
Boehringer Ingelheim conducts and sponsors clinical trials to establish safety and efficacy of the drugs we develop, either for use in their initial indication or in additional indications. read more
Boehringer Ingelheim Landmark Trials
In 2008, Boehringer Ingelheim presents results from large-scale, randomised, controlled landmark trials in cardiovascular, respiratory and cerebrovascular diseases. read more
ONTARGET®
This groundbreaking study programme explores therapeutic options in cardiovascular protection.
read more
PRoFESS®
The largest ever trial exploring therapeutic options in prevention of secondary stroke.
read more
UPLIFT®
UPLIFT® (Understanding Potential Long-term impacts on Function with Tiotropium) is a four-year landmark trial involving nearly 6.000 patients with COPD.
read more
RE-LY™
This trial evaluates the long-term anticoagulant therapy with dabigatran etexilate.
read more
